Literature DB >> 24940581

Reply to Gelman, Gaudart, Pericchi: More reasons to revise standards for statistical evidence.

Valen E Johnson.   

Abstract

Mesh：

Year:  2014        PMID： 24940581      PMCID： PMC4024871          DOI： 10.1073/pnas.1400338111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  7 in total

1.  Revised standards for statistical evidence.

Authors:  Valen E Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

2.  UNIFORMLY MOST POWERFUL BAYESIAN TESTS.

Authors:  Valen E Johnson
Journal:  Ann Stat       Date:  2013       Impact factor: 4.028

Review 3.  Trends in risks associated with new drug development: success rates for investigational drugs.

Authors:  J A DiMasi; L Feldman; A Seckler; A Wilson
Journal:  Clin Pharmacol Ther       Date:  2010-02-03       Impact factor: 6.875

4.  Revised evidence for statistical standards.

Authors:  Andrew Gelman; Christian P Robert
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-23       Impact factor: 11.205

5.  Adaptive revised standards for statistical evidence.

Authors:  Luis Pericchi; Carlos A B Pereira; María-Eglée Pérez
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-23       Impact factor: 11.205

Review 6.  Assumptions of expected benefits in randomized phase III trials evaluating systemic treatments for cancer.

Authors:  Hui K Gan; Benoit You; Gregory R Pond; Eric X Chen
Journal:  J Natl Cancer Inst       Date:  2012-04-06       Impact factor: 13.506

7.  Reproducibility issues in science, is P value really the only answer?

Authors:  Jean Gaudart; Laetitia Huiart; Paul J Milligan; Rodolphe Thiebaut; Roch Giorgi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-23       Impact factor: 11.205
  7 in total
  1 in total

1.  The earth is flat (p > 0.05): significance thresholds and the crisis of unreplicable research.

Authors:  Valentin Amrhein; Fränzi Korner-Nievergelt; Tobias Roth
Journal:  PeerJ       Date:  2017-07-07       Impact factor: 2.984
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.